MAP3K9-DT and cancer: Thirty-one proteins remain after screening (Table S1, protein name marked in red), in which YBX1 has been reported to interact with several oncogenic lncRNAs, including TP53TG1 (Diaz-Lagares et al, 2016), HULC (Li et al, 2017), HOXC-AS3 (Zhang et al, 2018), and lincNMR (Castello et al, 2012), thereby regulating cancer progression and oncogene expression.